E-mail ID : info@iamg.in |
Online Submission |
Click Here For Online Submission |
Instructions for authors |
Genetic Clinics |
Editorial board |
Get Our Newsletter |
Subscribe |
Send Your Feedback |
Feedback Form |
About Us |
IAMG |
Abstract
April to June 2019 | Vol. 12 | Issue 2 | Page 11-18 | |||
Epidermolysis Bullosa: An Update | |||
Neetu Bhari1 , Neerja Gupta2 | |||
1Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India 2Division of Genetics, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India | |||
Address for Correspondence Email: neerja17aiims@gmail.com | |||
Abstract Epidermolysis bullosa (EB) is caused by mutation in various components of the basement membrane zone and is characterized by increased fragility of skin and mucous membrane. There are four major types based on the level of split at the basement membrane zone – involvement of basal layer of epidermis in epidermolysis bullosa simplex (EBS), lamina lucida in junctional EB (JEB) and sublamina densa in dystrophic EB (DEB) while Kindler syndrome (KS) can exhibit multiple levels of split. More than 19 genes have been described resulting in the various subtypes of these 4 major types giving rise to diversity of phenotypic expressions. Diagnosis is based on the “onion skin approach’’ which includes clinical presentation, family history, antigen mapping and genetic mutation analysis. The main stay of management is supportive and wound care. The newer experimental therapies include gene therapy, fibroblast and protein therapy and mesenchymal and bone marrow transplantation. | |||
HTML Full Text | Download PDF |